MK-677 for Skin Health
Research, mechanism, dosing, and effectiveness of MK-677 for skin health.
Quick Answer
GH elevation from MK-677 supports skin collagen and health.
Evidence Level
Human Trials
Typical Dose
10-25 mg daily
Results Timeline
Skin improvements over 4-12 weeks
FDA Status
Research Only
How MK-677 Works for Skin Health
Growth hormone stimulates collagen production.
About Skin Health
Improvement of skin texture, tone, and overall appearance.
Research Evidence
Studies show increases in GH and IGF-1 levels, improved sleep quality, and increased lean body mass. However, a clinical trial was stopped early due to heart failure concerns in elderly patients. FDA lists MK-677 as having 'significant safety risks due to potential for congestive heart failure.' December 2025: FDA issued warning letters to companies selling MK-677. Never received FDA approval and remains an unapproved drug.
Dosing for Skin Health
Recommended Dose
10-25 mg daily
Frequency
Once daily, often before bed
Administration
Oral
Duration
8-12 weeks or longer
Note: Oral GH secretagogue. Can cause water retention, increased appetite, and blood sugar issues. Some cycle it, others run year-round.
What to Expect
Initial adjustment period. Some users may notice subtle changes.
Early benefits often become noticeable. Continue consistent use.
Most users report meaningful improvements by this point.
Full effects typically realized. Reassess and adjust as needed.
Possible Side Effects
Not everyone experiences these. Individual responses vary.
- •Increased appetite and hunger
- •Weight gain
- •Water retention/edema
- •Insulin resistance
- •Elevated blood glucose/hyperglycemia
- •Anxiety
Frequently Asked Questions
Does MK-677 help with skin health?
GH elevation from MK-677 supports skin collagen and health.
How does MK-677 work for skin health?
Growth hormone stimulates collagen production....
What dose of MK-677 should I use for skin health?
10-25 mg daily
How long until I see results?
Skin improvements over 4-12 weeks
Other Peptides for Skin Health
These peptides are also researched for skin health.
Ipamorelin
Clinical TrialsA selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin. Considered one of the safest GHRPs.
CJC-1295 (No DAC)
Clinical TrialsA synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates GH release from the pituitary. Often combined with a GHRP like Ipamorelin for synergistic effects.
Tesamorelin
FDAAn FDA-approved GHRH analog used to reduce excess abdominal fat in HIV-infected patients with lipodystrophy. New F8 formulation (Egrifta WR) approved March 2025 allows weekly reconstitution vs daily.
GHRP-6
Clinical TrialsOne of the first synthetic GH secretagogues developed. Strongly stimulates GH release and significantly increases appetite through ghrelin receptor activation.